Syncona Limited — Regulatory Filings 2018

Dec 17, 2018

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 7081K

Syncona Limited

17 December 2018

SYNCONA LIMITED

RELEASED IN ERROR

17 December 2018

The 'Change of Registered Office' announcement released on 17 December 2018 at 11.47am under RNS No 7019K was released in error and should be disregarded.

[ENDS]

Enquiries

Syncona Ltd

Annabel Clay  

Tel: +44 (0)20 3981 7928

Copies of this and other corporate information can be found on the company website at: www.synconaltd.com

About Syncona:

Syncona is a leading FTSE250 healthcare company focused on founding, building and funding global leaders in life science. Our vision is to deliver transformational treatments to patients in truly innovative areas of healthcare while generating superior returns for shareholders.

We seek to partner with the best, brightest and most ambitious minds in science to build globally competitive businesses.

We take a long-term view, underpinned by a deep pool of capital, and are established leaders in gene and cell therapy. We focus on delivering dramatic efficacy for patients in areas of high unmet need.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

CROFKODNBBDDBBD